NEUP
Price
$5.14
Change
+$0.03 (+0.59%)
Updated
Apr 17 closing price
Capitalization
17.39M
QLGN
Price
$3.24
Change
-$0.05 (-1.52%)
Updated
Apr 17 closing price
Capitalization
2.39M
Ad is loading...

NEUP vs QLGN

Header iconNEUP vs QLGN Comparison
Open Charts NEUP vs QLGNBanner chart's image
Neuphoria Therapeutics
Price$5.14
Change+$0.03 (+0.59%)
Volume$5.83K
Capitalization17.39M
Qualigen Therapeutics
Price$3.24
Change-$0.05 (-1.52%)
Volume$1.34K
Capitalization2.39M
NEUP vs QLGN Comparison Chart
Loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEUP vs. QLGN commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEUP is a Hold and QLGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (NEUP: $5.14 vs. QLGN: $3.24)
Brand notoriety: NEUP and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEUP: 5% vs. QLGN: 2%
Market capitalization -- NEUP: $17.39M vs. QLGN: $2.39M
NEUP [@Biotechnology] is valued at $17.39M. QLGN’s [@Biotechnology] market capitalization is $2.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEUP’s FA Score shows that 0 FA rating(s) are green whileQLGN’s FA Score has 1 green FA rating(s).

  • NEUP’s FA Score: 0 green, 5 red.
  • QLGN’s FA Score: 1 green, 4 red.
According to our system of comparison, QLGN is a better buy in the long-term than NEUP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUP’s TA Score shows that 4 TA indicator(s) are bullish while QLGN’s TA Score has 4 bullish TA indicator(s).

  • NEUP’s TA Score: 4 bullish, 6 bearish.
  • QLGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both NEUP and QLGN are a bad buy in the short-term.

Price Growth

NEUP (@Biotechnology) experienced а +4.88% price change this week, while QLGN (@Biotechnology) price change was +6.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

NEUP is expected to report earnings on Feb 20, 2025.

QLGN is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEUP($17.4M) has a higher market cap than QLGN($2.39M). NEUP has higher P/E ratio than QLGN: NEUP (0.47) vs QLGN (0.00). NEUP YTD gains are higher at: 49.831 vs. QLGN (-23.040). QLGN has higher annual earnings (EBITDA): -6.73M vs. NEUP (-14.17M). NEUP has more cash in the bank: 4.35M vs. QLGN (388K). NEUP has less debt than QLGN: NEUP (199K) vs QLGN (1.43M). NEUP has higher revenues than QLGN: NEUP (663K) vs QLGN (0).
NEUPQLGNNEUP / QLGN
Capitalization17.4M2.39M729%
EBITDA-14.17M-6.73M211%
Gain YTD49.831-23.040-216%
P/E Ratio0.470.0044,994%
Revenue663K0-
Total Cash4.35M388K1,120%
Total Debt199K1.43M14%
FUNDAMENTALS RATINGS
QLGN: Fundamental Ratings
QLGN
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
40
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUPQLGN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
59%
View a ticker or compare two or three
Ad is loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with QLGN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then QLGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
+0.57%
QLGN - NEUP
61%
Loosely correlated
-1.52%
CMND - NEUP
31%
Poorly correlated
+15.46%
MNPR - NEUP
25%
Poorly correlated
+4.13%
PPBT - NEUP
25%
Poorly correlated
+13.15%
SAGE - NEUP
23%
Poorly correlated
+0.81%
More

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with NEUP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then NEUP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
-1.52%
NEUP - QLGN
61%
Loosely correlated
+0.57%
ZLDAF - QLGN
34%
Loosely correlated
N/A
TIL - QLGN
31%
Poorly correlated
+1.01%
ZVSA - QLGN
28%
Poorly correlated
-1.89%
NTLA - QLGN
27%
Poorly correlated
+5.39%
More